在TAVR手术挑战和结果后感染性内心炎
Andrea Reiter1, Julia Schreyer1, Melchior Burri1
1Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, School of Medicine & Health, Technical University of Munich, 80636 Munich, Germany.
Journal of clinical medicine
|November 13, 2025
概括
经过透气管大动脉置换后,用于感染性内心炎的外科大动脉置换具有高的早期死亡率. 较高的术前风险分数和术后透析预测死亡,但对于医院幸存者来说,长期生存是有利的.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
- 传染性疾病 传染性疾病
背景情况:
- 通过导管大动脉置换 (TAVR) 后的传染性内心炎 (IE) 是一种严重的并发症.
- 感染过导管心脏门 (THV) 的手术探索是复杂的,并且与高死亡率有关.
- 关于术后死亡和长期结果的风险因素的数据有限.
研究的目的:
- 为了确定在TAVR后对IE进行大动脉置换手术 (SAVR) 的患者死亡率的预测因素.
主要方法:
- 一项病例对照研究比较了15名在外科手术期间死亡的患者 (病例) 与35名幸存者 (对照) 进行TAVR后IESAVR.
- 患者在2008年2月至2023年12月期间接受治疗.
- 评估了医院幸存者的长期结果.
主要成果:
- 病例显示左下心室功能和更高的后勤EuroSCORE和STS-PROM手术前.
- 术后透析在病例中更频繁 (44%对25.7%).
- 30天生存率为79.8%,一年生存率为67.4%;35名医院幸存者中有31人在随访时仍然活着.
结论:
- 在TAVR后的IE的SAVR具有相当大的早期死亡率 (30天后18.1%,1年后32.6%).
- 术前风险得分升高和术后透析的需要与术后死亡有关.
- 医院幸存者经历了有利的长期结果,大多数人实现了独立生活.
相关概念视频
Endocarditis III: Medical Management
205
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
205
Endocarditis IV: Nursing Management
308
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
308
Endocarditis I: Introduction
376
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
376
Endocarditis II: Clinical Features of Infective Endocarditis
394
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
394
Pericarditis III: Medical Management
294
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
294
Myocarditis III: Medical Management
168
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
168


